Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,107 public trials 145 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Active, Not Recruiting

A Study of Fedratinib in Japanese Subjects With DIPSS (Dynamic International Prognostic Scoring System)- Intermediate or High-risk Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (Post-PV MF), or Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)

NCT04446650

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Local Institution - 021 Suwa, Nagano, Japan
  • Local Institution - 001 Bunkyo-ku, Tokyo, Japan
  • Local Institution - 006 Chūō, Yamanashi, Japan
  • Local Institution - 002 Aomori, Japan
View all 21 locations
View Trial Details
Active, Not Recruiting

Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia

NCT05384587

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia - Chronic Phase, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Alaska Oncology and Hematology Anchorage, Alaska, United States
  • City of Hope Phoenix Scottsdale, Arizona, United States
  • USO Arizona Oncology Tucson, Arizona, United States
View all 80 locations
View Trial Details
Active, Not Recruiting

2nd or 3rd TKI-stop After 2 Years Nilotinib Pre-treatment in CML-patients

NCT02917720

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Universitätsklinikum Freiburg Freiburg im Breisgau, Baden-Wurttemberg, Germany
  • Universitätsmedizin Mannheim Mannheim, Baden-Wurttemberg, Germany
  • Klinikum rechts der Isar München, Bavaria, Germany
  • Medizinische Hochschule Hannover Hannover, North Rhine-Westphalia, Germany
View all 15 locations
View Trial Details
Active, Not Recruiting

Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia

NCT04258943

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, +20 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
View all 59 locations
View Trial Details
Active, Not Recruiting

A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV

NCT05481151

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +12 more
Locations
  • Baptist MD Anderson Jacksonville, Florida, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
  • University of Kansas Medical Center Westwood, Kansas, United States
  • Mercy Health Paducah, Kentucky, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera

NCT05210790

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Infirmary Cancer Care Mobile, Alabama, United States
  • Palo Verde Hematology-Oncology Glendale, Arizona, United States
  • City of Hope Medical Center, Duarte Duarte, California, United States
  • California Cancer Associates for Research and Excellence - Fresno Fresno, California, United States
View all 184 locations
View Trial Details

Related conditions